Drug Type Small molecule drug |
Synonyms AEGR 427 implitapide, AEGR-427, BAY 13-9952 + [1] |
Target |
Mechanism MTTP inhibitors(Microsomal triglyceride transfer protein inhibitors) |
Active Indication- |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
RegulationOrphan Drug (US) |
Molecular FormulaC35H37N3O2 |
InChIKeyKIMRCJZMVARVSU-DITALETJSA-N |
CAS Registry177469-96-4 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hypertriglyceridemia | Phase 2 | US | 01 Oct 2004 | |
Hypertriglyceridemia | Phase 2 | NL | 01 Oct 2004 | |
Hypertriglyceridemia | Phase 2 | NO | 01 Oct 2004 | |
Heterozygous familial hypercholesterolemia | Phase 2 | US | 01 Oct 2003 | |
Heterozygous familial hypercholesterolemia | Phase 2 | NL | 01 Oct 2003 | |
Heterozygous familial hypercholesterolemia | Phase 2 | NO | 01 Oct 2003 | |
Homozygous familial hypercholesterolemia | Phase 2 | US | 01 Sep 2003 | |
Homozygous familial hypercholesterolemia | Phase 2 | CA | 01 Sep 2003 | |
Homozygous familial hypercholesterolemia | Phase 2 | IL | 01 Sep 2003 | |
Homozygous familial hypercholesterolemia | Phase 2 | NL | 01 Sep 2003 |